Demand Generation Manager
in health
A Demand Generation Manager builds predictable pipeline for health and life-sciences companies without overstepping the strict rules on claims and trust.
A Demand Generation Manager in health and life sciences is accountable for creating predictable, measurable demand for a product or service and converting that demand into qualified pipeline that Sales (or a clinical partnerships team) can progress. In practice, they own the link between marketing activity and commercial outcomes: not "more marketing", but the right volume and quality of opportunities for the business to hit growth targets without compromising trust, compliance, or patient impact.
This role exists because buying in this sector is rarely driven by impulse. Whether the employer is a pharma company, a medical device maker, a diagnostics lab, a contract research organisation (CRO), a digital health scale-up, or a supplier selling into NHS trusts, the people on the other side of the table can include clinicians, operations leaders, procurement, information governance, and finance. Each has different incentives and risk thresholds. A Demand Generation Manager helps the organisation move from hopeful outreach to an intentional revenue engine: defining target segments, shaping journeys, setting performance standards, and owning the outcomes those decisions create.
In most health and life-sciences organisations, the role sits within Marketing and partners tightly with Sales, Partnerships, Product Marketing, RevOps, Medical or Regulatory affairs, and often Compliance or InfoSec. The core of the job is ownership: owning pipeline targets, owning the integrity of how demand is generated, and owning the decisions that trade speed against safety and long-term access to healthcare buyers.
How this role differs in health and life sciences
In many unregulated B2B categories, demand generation can optimise aggressively for volume and rapid iteration. Health and life sciences still needs speed and learning, but the cost of getting it wrong is higher: reputational damage can be harder to recover from, data handling expectations are stricter, and decision-makers may require deeper evidence before they engage.
Claims are the sharpest difference. If you market medicines or medical devices, what you can say is governed, not just guided. The MHRA sets the rules on advertising and promotion, and in pharma the ABPI Code of Practice (policed by the PMCPA) shapes almost every word that reaches a prescriber. A landing page headline that is normal in software can be a breach in pharma. So "good copy" here means copy that is accurate, balanced, and defensible, not just persuasive.
The sector also changes what "conversion" means. You may be optimising not just for marketing-qualified to sales-qualified handover, but for readiness to pass clinical scrutiny, procurement frameworks, and security reviews. NHS buyers in particular weigh evidence and value carefully, and NICE guidance or health technology assessment can decide whether a product is even considered. Messaging that skips the proof rarely survives that journey.
Finally, demand generation here is often closer to category-building. Many products introduce new workflows, new clinical pathways, or new science, so the job becomes as much about earning permission to be considered (through trust, clarity, and proof) as it is about capturing demand that already exists.
Core responsibilities in health and life sciences
Day to day, a Demand Generation Manager is accountable for shaping and running the engine that turns a defined audience into measurable pipeline while protecting the organisation from preventable risk. They decide which segments to prioritise, what "qualified" means in a healthcare buying context, and how much of the funnel can be product-led versus sales-led. That accountability shows up in weekly decisions: which campaigns to scale, which to pause, and which to redesign because lead quality is harming sales efficiency or because the message creates compliance discomfort.
Verb-led, the work usually includes:
- Own pipeline and revenue-influence targets, and report against them honestly so the business can invest with confidence.
- Define and defend qualification standards with Sales and RevOps so "marketing-sourced" actually means something in a long healthcare buying cycle.
- Design multi-channel programmes (paid, content, events, email, partnerships) that respect long evaluation cycles and the need for evidence.
- Pressure-test every claim and asset against MHRA rules and, in pharma, the ABPI Code before it ships, working with Medical or Regulatory reviewers early rather than late.
- Build segment and account strategies for the real settings you sell into: NHS trusts, pharma, biotech, medtech, diagnostics labs, CROs, and scale-ups.
- Run experiments that improve outcomes without relying on questionable targeting, exaggerated urgency, or shortcuts with sensitive data.
- Keep the operational plumbing trustworthy: tracking, lead routing, attribution, CRM hygiene, and the shared definitions that stop "marketing versus sales" arguments.
They work under constraints that are more rigid than in many industries. If you cannot use certain targeting, cannot phrase claims in a particular way, or must treat certain data with heightened caution, then performance is won through better judgement rather than more aggression. Strong demand generation managers make these trade-offs explicit: they choose channels and journeys that produce credible intent, even if that means fewer leads, because the downstream cost of low-trust demand (sales time, legal review cycles, churn risk) is too high.
Skills and competencies for health and life sciences
| Core Skill | Health and life-sciences specific requirement | Reason or Impact |
|---|---|---|
| Commercial accountability | Comfort owning pipeline targets where multiple stakeholders influence conversion (clinical, procurement, information governance, finance) | Prevents over-optimising for lead volume and refocuses work on opportunities that can realistically close in healthcare buying cycles |
| Claims and compliance judgement | Ability to keep messaging accurate and balanced under MHRA advertising rules and the ABPI Code so it survives Medical or Regulatory review | Protects the licence to promote, reduces rework with reviewers, and avoids campaigns that trigger complaints or have to be pulled |
| Stakeholder alignment | Aligning Sales and Partnerships, Product Marketing, RevOps, Medical, Regulatory, and compliance-minded teams on definitions and priorities | Creates consistent qualification standards and removes the "marketing versus sales" disputes that slow growth |
| Evidence-led funnel design | Designing journeys that respect long evaluation cycles, NICE and HTA expectations, and the buyer's need for proof, not just clicks | Improves conversion by matching content and proof points to real buyer concerns and decision stages |
| Data discipline | Treating performance measurement as an operational system (tracking, routing, attribution, governance) and respecting health-data sensitivity | Enables confident budget decisions and reduces the risk of misreporting performance in a high-stakes context |
| Experimentation under constraints | Running tests that improve outcomes without questionable targeting, exaggerated urgency, or shortcuts with sensitive data | Sustains learning velocity while maintaining compliance and trust expectations |
| Cross-functional execution | Managing dependencies across teams where Medical, Regulatory, and security input can gate a launch | Keeps delivery predictable and reduces the "everything takes longer" drag that can stall growth teams in regulated markets |
Salary ranges in UK health and life sciences
Compensation for Demand Generation Managers in UK health and life sciences typically reflects the commercial criticality of pipeline ownership, the complexity of the buying cycle, and the level of autonomy in setting strategy and budget. Pay tends to increase when the role is accountable for revenue outcomes across multiple channels and segments, when it influences go-to-market strategy, and when the organisation operates in more regulated or trust-sensitive contexts that demand tighter judgement and governance. Location still matters, especially for London and the South East, though remote and national setups can narrow the gap.
| Experience level | Estimated annual salary range | What drives compensation |
|---|---|---|
| Junior | London and South East: £38,000 to £48,000 Rest of UK: £33,000 to £43,000 | Execution scope (single channel versus multi-channel support), closeness to revenue targets, and whether the role owns a full funnel stage or supports a senior owner |
| Mid-level | London and South East: £48,000 to £62,000 Rest of UK: £42,000 to £56,000 | Ownership of campaigns and reporting, budget responsibility, channel mix, and expectations around lead quality and sales alignment |
| Senior | London and South East: £62,000 to £80,000 Rest of UK: £55,000 to £72,000 | End-to-end funnel ownership, strategic segment choices, measurable pipeline contribution, and complexity of the buyer journey (clinical, procurement, and security gates) |
| Lead | London and South East: £80,000 to £100,000 Rest of UK: £70,000 to £90,000 | Leading the demand engine across teams and channels, setting targets and definitions, managing significant budgets, and influencing go-to-market planning with Sales and RevOps |
| Head / Director | London and South East: £100,000 to £140,000 Rest of UK: £85,000 to £120,000 | Function ownership and accountability for predictable pipeline, leadership scope (team size and remit), board-level visibility, and the cost of being wrong on brand, compliance, and revenue |
Sources: Glassdoor UK (senior demand generation roles in London advertised around £95,000 to £105,000), PayScale UK (base around £33,000 to £79,000 plus bonus), and Intelligent People (experienced demand generation managers around £60,000 to £70,000). Treat these as a guide; real offers move with employer, setting and specialism.
Beyond base salary, typical add-ons include an annual performance bonus (often tied to pipeline, revenue influence, or company targets) and, more commonly in scale-ups, equity or stock options. On-call allowances are not usually a feature for demand generation roles, but total compensation can rise when the role carries high commercial pressure, manages large paid budgets, operates across multiple markets, or is expected to deliver against ambitious targets with limited brand maturity or strict governance constraints.
Career pathways
Many Demand Generation Managers enter health and life sciences from B2B marketing roles such as growth marketing, performance marketing, lifecycle or CRM, content-led acquisition, or marketing operations, often after proving they can own a measurable part of a funnel. Others transition from agency backgrounds where they have run multi-channel programmes, then move in-house to take responsibility for outcomes rather than deliverables. A smaller group arrives from medical communications or product marketing inside pharma and medtech, bringing the claims fluency that takes others time to build.
Progression is usually less about titles and more about increasing ownership. Early on, success looks like running campaigns reliably and improving conversion with disciplined measurement. Mid-career, the scope expands to owning qualification standards, budget allocation across channels, and tighter alignment with Sales and RevOps. Senior and Lead levels typically add strategic responsibility: segment prioritisation, forecasting, and building repeatable motions that survive team changes and budget cycles. Head or Director progression comes from building a durable revenue engine, one that balances growth with trust, evidence, and operational control.
FAQ
Do I need a clinical or science background to be a Demand Generation Manager in health and life sciences?
Usually not, but you do need comfort working with clinical, medical, and regulatory stakeholders and translating evidence into clear, responsible messaging. Hiring teams tend to look for judgement and learning speed over a science degree. The strongest candidates show they can market in trust-sensitive environments without overselling.
How will I be evaluated: leads, pipeline, or revenue?
Most roles are measured on qualified pipeline contribution and lead-to-opportunity quality, not just lead volume. Expect scrutiny on whether your programmes help Sales progress deals through real buying stages, including procurement and security reviews. You will often be assessed on how well you define and defend "quality" with data.
Will I run paid acquisition the same way as in unregulated B2B?
Sometimes, but the approach is typically more conservative and evidence-led, especially where claims and data handling require care. Where you are promoting medicines or devices, MHRA rules and the ABPI Code set hard limits on what you can say. You may need more emphasis on education, proof points, and longer nurture paths than pure direct-response tactics, so be ready to explain how you balance growth targets with credibility and compliance.
Find your next role
If you are ready to own pipeline growth in a trust-sensitive market, search Demand Generation Manager roles across UK health and life sciences on Meeveem.